These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 23466914)
1. Comparative epidemiology of bacteremia due to methicillin-resistant Staphylococcus aureus between older and younger adults: a propensity score analysis. Kullar R; Rybak MJ; Kaye KS Infect Control Hosp Epidemiol; 2013 Apr; 34(4):400-6. PubMed ID: 23466914 [TBL] [Abstract][Full Text] [Related]
2. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy. Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982 [TBL] [Abstract][Full Text] [Related]
3. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia. Kullar R; Davis SL; Kaye KS; Levine DP; Pogue JM; Rybak MJ Pharmacotherapy; 2013 Jan; 33(1):3-10. PubMed ID: 23307539 [TBL] [Abstract][Full Text] [Related]
4. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221 [TBL] [Abstract][Full Text] [Related]
5. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients. Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238 [TBL] [Abstract][Full Text] [Related]
6. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study. Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272 [TBL] [Abstract][Full Text] [Related]
7. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK. Lewis T; Chaudhry R; Nightingale P; Lambert P; Das I Int J Infect Dis; 2011 Feb; 15(2):e131-5. PubMed ID: 21134776 [TBL] [Abstract][Full Text] [Related]
8. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Kullar R; Davis SL; Levine DP; Rybak MJ Clin Infect Dis; 2011 Apr; 52(8):975-81. PubMed ID: 21460309 [TBL] [Abstract][Full Text] [Related]
9. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia. Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337 [TBL] [Abstract][Full Text] [Related]
10. Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin . Lodise TP; Drusano GL; Lazariu V; El-Fawal N; Evans A; Graffunder E; Stellrecht K; Mendes RE; Jones RN; Cosler L; McNutt LA J Antimicrob Chemother; 2014 Sep; 69(9):2547-55. PubMed ID: 24840624 [TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355 [TBL] [Abstract][Full Text] [Related]
12. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia. Jung Y; Song KH; Cho Je; Kim HS; Kim NH; Kim TS; Choe PG; Chung JY; Park WB; Bang JH; Kim ES; Park KU; Park SW; Kim HB; Kim NJ; Oh MD Int J Antimicrob Agents; 2014 Feb; 43(2):179-83. PubMed ID: 24315788 [TBL] [Abstract][Full Text] [Related]
13. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia. Yeh YC; Yeh KM; Lin TY; Chiu SK; Yang YS; Wang YC; Lin JC J Microbiol Immunol Infect; 2012 Jun; 45(3):214-20. PubMed ID: 22571999 [TBL] [Abstract][Full Text] [Related]
14. Outcomes and costs associated with a history of vancomycin exposure in patients with MRSA-related complicated bacteremia and infective endocarditis. Brown J; Brown KA; Forrest A Clin Ther; 2011 Oct; 33(10):1475-82. PubMed ID: 21925733 [TBL] [Abstract][Full Text] [Related]
15. Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study. Chang HJ; Hsu PC; Yang CC; Siu LK; Kuo AJ; Chia JH; Wu TL; Huang CT; Lee MH J Antimicrob Chemother; 2012 Mar; 67(3):736-41. PubMed ID: 22169187 [TBL] [Abstract][Full Text] [Related]
16. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575 [TBL] [Abstract][Full Text] [Related]
17. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Moore CL; Osaki-Kiyan P; Haque NZ; Perri MB; Donabedian S; Zervos MJ Clin Infect Dis; 2012 Jan; 54(1):51-8. PubMed ID: 22109947 [TBL] [Abstract][Full Text] [Related]
19. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence. Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021 [TBL] [Abstract][Full Text] [Related]
20. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents. Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]